ANALYST COVERAGE

Analyst Coverage

Delek Group is followed by the
analysts listed below

Please note that any opinions, estimates or forecasts regarding Delek Group's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Delek Group or its management. Delek Group does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

FIRM	ANALYST	PHONE	EMAIL
Bank of America Merrill Lynch	Rafal Gutaj	+44 20 7995 5840	[email protected]
Barclays Capital	Tavy Rosner	+972 3 623 8628	[email protected]
IBI – Israel Brokerage Investment	Liran Lublin	+972 3 3-5193430	[email protected]
Leader Capital Markets	Yehonatan Shohat	+972 3 6845731	[email protected]
Psagot Investment House	Noam Pincu	+972 3 796 8818	[email protected]

DELEK GROUP
HEADQUARTERS

Accessibility

Designed and built by

2018 © Copyright Delek Group. All Rights Reserved.

Waiver of Rule 9 of the UK City Code on Takeovers and Mergers

Important Disclaimer

ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS OR REGULATIONS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THIS MICROSITE. THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSIBLE BY PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH CONSENT OR OTHER FORMALITY WHICH DELEK REGARDS AS UNDULY ONEROUS.

As a consequence of Delek Group Ltd.’s (“Delek”) anticipated shareholding following completion of the proposed combination between Capricorn Energy PLC (“Capricorn“) and NewMed Energy Limited Partnership (“NewMed“) (the “Recommended Combination”), the Recommended Combination is conditional on a Rule 9 waiver from the UK Takeover Panel in order to disapply mandatory offer requirements pursuant to Rule 9 of the UK City Code on Takeovers and Mergers (the “Rule 9 Waiver”).

Access to the Information

You are attempting to enter the part of the website that is designated for the publication of documents and information in connection with the Recommended Combination and the Rule 9 Waiver. The materials you are seeking to access are made available in good faith and for informational purposes only and are subject to the terms and conditions set out below. Any person seeking access to this part of Delek’s website represents and warrants to Delek that they are doing so for informational purposes only. Making the information available in electronic format is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Recommended Combination or the Rule 9 Waiver.

If you would like to view this part of the website, please read this notice carefully. This notice applies to all persons who view this part of the website and, depending on where you are located, may affect your rights or responsibilities. Delek reserves the right to amend or update this notice at any time and you should, therefore, read it in full each time you visit the site. In addition, the contents of this part of the website may be amended at any time, in whole or in part, at the sole discretion of Delek.

Overseas jurisdictions

Viewing the materials you are seeking to access may be restricted under securities laws in certain jurisdictions. In certain jurisdictions, only certain categories of persons may be allowed to view such materials. All persons who wish to view the information contained in this part of the website must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so and should inform themselves about, and observe, any legal or regulatory requirements applicable in their jurisdiction.

The materials contained in this part of the website are not directed at or intended to be accessible by persons resident in any jurisdiction if to do so would constitute a violation of the relevant laws or regulations of that jurisdiction.

YOU SHOULD NOT DOWNLOAD, MAIL, FORWARD, DISTRIBUTE, SEND OR SHARE THE INFORMATION OR DOCUMENTS CONTAINED ON THIS MICROSITE TO ANY PERSON. IN PARTICULAR, YOU SHOULD NOT MAIL, FORWARD, DISTRIBUTE OR SEND THE INFORMATION OR DOCUMENTS CONTAINED THEREIN TO ANY JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO.

This part of the website contains information that has been prepared for the purposes of complying with the UK City Code on Takeovers and Mergers and the information disclosed may not be the same as that which would have been disclosed if this information had been prepared in accordance with the laws and regulations of any jurisdiction outside of England and Wales.

It is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements. If you are in any doubt, you should not continue to seek to access this part of the website.

Responsibility

In relation to any materials related to the Recommended Combination that are accessible on this part of the website, please note any statement of responsibility contained therein.

Confirmation of understanding and acceptance

I have read and understood the notice set out above and I agree to be bound by its terms.
I am not (nor do I act on behalf of someone who is) resident in any country that renders the accessing of the materials on this website or parts of it illegal.
I will not print, download, or otherwise seek to copy, mail, forward, distribute or send any of the materials on this part of the website to any other person at any time.
I represent and warrant to Delek that I intend to access this part of the website for informational purposes only.

If you are unable to agree, you should click “I DECLINE” and you will not be able to view information about the Recommended Combination and the Rule 9 Waiver.